Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Impact of CRISP on Self-Efficacy, Loneliness, and Depression [NA]
A completed clinical trial evaluating the CRISP program's impact on self-efficacy, loneliness, and depression in people with Multiple Sclero…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Multiple Sclerosis and Progressive Resistance Training [NA]
A completed clinical trial evaluated progressive resistance training in individuals with Relapsing-Remitting Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity [Phase 2]
Phase 2 study of darifenacin in patients with multiple sclerosis and neurogenic detrusor overactivity was terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior [Phase 1, Phase 2]
This trial update reports the completion of a Phase 1/2 study comparing exercise versus behavioral intervention for fall risk reduction in a…
-
CLINICAL_TRIALS research · 2014-11-25Clinical Trial Update: Project FARMS: Fall Risk Reduction in Multiple Sclerosis [Phase 1]
Phase 1 clinical trial update for Project FARMS focusing on fall risk reduction in Multiple Sclerosis; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Chronotherapy in Acute Multiple Sclerosis (MS) Attack [NA]
The clinical trial investigating chronotherapy for acute multiple sclerosis attacks has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Mindfulness Based Stress Reduction in Multiple Sclerosis (MS) [NA]
The document reports the completion of a clinical trial evaluating Mindfulness-Based Stress Reduction in people with Multiple Sclerosis.
-
FDA approval · 2014-11-14FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for TECFIDERA (dimethyl fumarate) filed by Biogen.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period
An observational study funded by Merck KGaA investigates the progression from clinically isolated syndrome to multiple sclerosis over two ye…
-
CLINICAL_TRIALS research · 2014-11-07Clinical Trial Update: Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity [Phase 4]
Phase 4 trial evaluating whether transcranial magnetic stimulation reduces spasticity in patients with cerebral and spinal injuries, includi…
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination [Phase 2]
Phase 2 study evaluating whether combining mitoxantrone with dexrazoxane reduces cardiac problems in multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Pilot Study of Free From Falls Program in Multiple Sclerosis [NA]
A completed pilot study evaluating the Free From Falls program for people with multiple sclerosis.
-
FDA approval · 2014-10-17FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
The FDA approved a supplemental application for AUBAGIO (teriflunomide) submitted by Genzyme Corporation.
-
CLINICAL_TRIALS research · 2014-10-15Clinical Trial Update: Exercise Intensity and Immune Function in Multiple Sclerosis [NA]
An update on a clinical trial evaluating how exercise intensity affects immune function in individuals with multiple sclerosis; the current …
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis [Phase 1, Phase 2]
A Phase Ib/Phase 2 trial of MOR103 for multiple sclerosis has completed and posted results.
-
CLINICAL_TRIALS withdrawal · 2014-10-09Clinical Trial Update: Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness [NA]
The clinical trial evaluating treadmill training for chronic multiple sclerosis, assessing efficacy and cost-effectiveness, has been withdra…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS [Phase 4]
Phase 4 trial update assessing the efficacy of dalfampridine on upper extremity function in patients with multiple sclerosis.
-
FDA approval · 2014-09-30FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
FDA approved a supplemental application for AMPYRA (dalfampridine) from Merz Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Safety and Efficacy of BMMNC in Multiple Sclerosis (MS) [Phase 1, Phase 2]
This clinical trial update examines the safety and efficacy of bone marrow mononuclear cells (BMMNC) in multiple sclerosis across Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations [Phase 4]
A Phase 4 pilot trial comparing 14-day versus 5-day subcutaneous ACTHAR Gel regimens for multiple sclerosis exacerbations has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Brain Functional Connectivity Changes Following Cognitive Rehabilitation in Multiple Sclerosis: an fMRI Study [NA]
A completed clinical trial update reporting changes in brain functional connectivity after cognitive rehabilitation in people with multiple …
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.
This clinical trial update discusses persistence and adherence, quality of life, and treatment satisfaction among patients using the Avonex …
-
EMA withdrawal · 2014-09-01EMA Refused: Nerventra (laquinimod) — Teva Pharma GmbH
EMA refused Teva's Nerventra (laquinimod) application for multiple sclerosis, indicating a negative regulatory decision.
-
FDA approval · 2014-08-29FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for ZANAFLEX (tizanidine hydrochloride) submitted by Covis Pharma US, Inc.
-
FDA approval · 2014-08-28FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)
The FDA has approved a supplemental application for Avonex (interferon beta-1a) filed by Biogen.